TRIPC Polyclonal Antibody

Component of PA700, an ATP-dependent multisubunit protein that activates the proteolytic activities of the multifunctional proteinase (20S proteasome) of the 26S complex. Specifically interacts with the ligand binding domain of the thyroid hormone receptor (in a thyroid hormone T3-independent manner) and with retinoid X receptor (RXR). Could be E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.,miscellaneous:A cysteine residue is required for ubiquitin-thioester formation.,pathway:Protein modification; protein ubiquitination.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,Belongs to the UPL family. K-HECT subfamily.,Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.,Contains 1 WWE domain.,subunit:PA700 is composed of at least 16 distinct peptides ranging from 20-112 kDa.,

Introducing the TRIPC Polyclonal Antibody, a cutting-edge solution designed to revolutionize the field of immunology. This meticulously crafted product is meticulously engineered to deliver unparalleled accuracy and reliability in detecting target antigens.

The TRIPC Polyclonal Antibody boasts a superior level of specificity, ensuring precise identification of the desired antigen. Its exceptional sensitivity enables the detection of even the most minute quantities, guaranteeing optimal results in various applications.

Crafted with utmost precision, this antibody undergoes rigorous quality control measures to ensure consistent performance and reproducibility. Its robust formulation guarantees long-lasting stability, allowing for extended shelf life and reliable usage.

The TRIPC Polyclonal Antibody is meticulously designed to cater to a wide range of research needs. Its versatility enables seamless integration into various experimental techniques, including immunohistochemistry, western blotting, and flow cytometry. This antibody's adaptability ensures optimal performance across diverse sample types and species.

Furthermore, the TRIPC Polyclonal Antibody is backed by a team of expert scientists and researchers, who are readily available to provide comprehensive technical support and guidance. Their expertise ensures seamless integration of this product into your research workflow, empowering you to achieve groundbreaking results.

In summary, the TRIPC Polyclonal Antibody is a state-of-the-art solution that sets new standards in immunological research. Its exceptional specificity, sensitivity, and versatility make it an indispensable tool for scientists and researchers alike. Experience the pinnacle of immunological advancements with the TRIPC Polyclonal Antibody.